Gamma-glutamyl transferase (GGT) is a enzymatic liver function test available for several decades, used as a sensitive indicator of alcohol ingestion, hepatic inflammation, fatty liver disease, and hepatitis. Recent longitudinal and cross-sectional investigational studies have suggested its independent role in the pathogenenesis and clinical evolution of cardiovascular deseases. Serum gamma-glutamyltransferase (GGT) have been associated with many cardiovascular des eases risks or components of the cardiovascular deseases. In this study, the authors enrolled 162 adults (mean age 46.9 + or - 7.2 years; 27 female (16.7 percent) and 135 men (83.3 percent), 73 with Metabolic Syndrome (MetS) and 89 without (controls) as defined by the ATP-III criteria. The aim of study is to evaluate serum GGT activity of the patiens with MetS. The resuts showed that: compared with controls, patients with MetS had significantly higher serum GGT (55.4 + or - 36.4 U/I) vs (36.5 + or - 20.6) U/I ; p0.001). Serum GGT level showed significant correlations waist (r
- Đăng nhập để gửi ý kiến